Education
About Us
Working with TipRanks
Follow Us
BONESUPPORT HOLDING AB (DE:2B4)
FRANKFURT:2B4
RESEARCH TOOLSreports
2B4 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€20.50 - €39.42
Previous CloseN/A
Volume165.00
Average Volume (3M)90.00
Market Cap
$1.70B
Enterprise Value€18.40B
Total Cash (Recent Filing)$309.68M
Total Debt (Recent Filing)$12.68M
Price to Earnings (P/E)129.8
Beta-0.05
Next Earnings
Oct 23, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding65,859,190
10 Day Avg. Volume39
30 Day Avg. Volume90
Financial Highlights & Ratios
PEG Ratio-4.14
Price to Book (P/B)34.90
Price to Sales (P/S)28.25
P/FCF Ratio423.67
Enterprise Value/Market Cap10.82
Enterprise Value/Revenue17.31
Enterprise Value/Gross Profit18.70
Enterprise Value/Ebitda93.61
Forecast
1Y Price Target
$32.00Price Target Upside21.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
BONESUPPORT HOLDING AB News
2B4 FAQ
What was BONESUPPORT HOLDING AB’s price range in the past 12 months?
BONESUPPORT HOLDING AB lowest stock price was €20.50 and its highest was €39.42 in the past 12 months.
What is BONESUPPORT HOLDING AB’s market cap?
BONESUPPORT HOLDING AB’s market cap is $1.70B.
When is BONESUPPORT HOLDING AB’s upcoming earnings report date?
BONESUPPORT HOLDING AB’s upcoming earnings report date is Oct 23, 2025 which is in 60 days.
How were BONESUPPORT HOLDING AB’s earnings last quarter?
BONESUPPORT HOLDING AB released its earnings results on Jul 15, 2025. The company reported €0.071 earnings per share for the quarter, beating the consensus estimate of €0.066 by €0.005.
Is BONESUPPORT HOLDING AB overvalued?
According to Wall Street analysts BONESUPPORT HOLDING AB’s price is currently Undervalued.
Does BONESUPPORT HOLDING AB pay dividends?
BONESUPPORT HOLDING AB does not currently pay dividends.
What is BONESUPPORT HOLDING AB’s EPS estimate?
BONESUPPORT HOLDING AB’s EPS estimate is 0.09.
How many shares outstanding does BONESUPPORT HOLDING AB have?
BONESUPPORT HOLDING AB has 65,859,190 shares outstanding.
What happened to BONESUPPORT HOLDING AB’s price movement after its last earnings report?
BONESUPPORT HOLDING AB reported an EPS of €0.071 in its last earnings report, beating expectations of €0.066. Following the earnings report the stock price went up 3.715%.
Which hedge fund is a major shareholder of BONESUPPORT HOLDING AB?
Currently, no hedge funds are holding shares in DE:2B4
Company Description
BONESUPPORT HOLDING AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
2B4 Company Deck
2B4 Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Bonesupport's Q3 2024 earnings call highlighted robust sales growth, particularly for CERAMENT G in the U.S., and successful clinical outcomes from the SOLARIO study. While there were some challenges in Europe and currency impacts, the overall sentiment is largely positive due to strong market performance and promising future prospects.View all DE:2B4 earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
11.40%
Mutual Funds
― Other Institutional Investors
83.45% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---